Article
5-HT2 and 5-HT2B antagonists attenuate pro-fibrotic phenotype in human adult dermal fibroblasts by blocking TGF-β1 induced non-canonical signaling pathways including STAT3 : implications for fibrotic diseases like scleroderma.
International journal of rheumatic diseases - 1 Dec 2018
Chaturvedi Saurabh, Misra Durga Prasanna, Prasad Narayan, Rastogi Kailash, Singh Harshit, Rai Mohit Kumar, Agarwal Vikas
Abstract excerpt
BACKGROUND: Release of 5-hydroxytryptamine (5-HT; serotonin) from activated platelets following microvascular injury leads to tissue fibrosis. 5-HT strongly induces extracellular matrix synthesis in dermal fibroblasts in a transforming growth factor beta 1 (TGF-β1)-dependent manner. AIM: To evaluate anti-fibrotic properties of inhibitors of 5-HT2 and 5-HT2B (terguride, SB204741) respectively in human adult dermal...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.